The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Recent Progress in Histone Demethylase Inhibitors.EBI
University Of Oxford
Inhibition of Histone Demethylases Offers a Novel and Promising Approach for the Treatment of Cancer and Other Diseases.EBI
Therachem Research Medilab (India)
Development of multitargeted inhibitors of both the insulin-like growth factor receptor (IGF-IR) and members of the epidermal growth factor family of receptor tyrosine kinases.BDB
Abbott Laboratories
Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.BDB
Toronto General Research Institute
Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.BDB
University Of Queensland
Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight.BDB
University Of Padova
Synthetic Lethality Triggered by Combining Olaparib with BRCA2-Rad51 Disruptors.BDB
Istituto Italiano Di Tecnologia